{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T14:24:07Z","timestamp":1783347847194,"version":"3.54.6"},"reference-count":99,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"unspecified","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["226543\/Z\/22\/Z"],"award-info":[{"award-number":["226543\/Z\/22\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["PDP Postdoctoral Fellowship"],"award-info":[{"award-number":["PDP Postdoctoral Fellowship"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"crossref","award":["CSA2022GloPID-R -3387"],"award-info":[{"award-number":["CSA2022GloPID-R -3387"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["bmjph"],"accepted":{"date-parts":[[2026,5,20]]},"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Henipaviruses have been identified as priority pathogens by the WHO for research and development. We applied a rapid research needs appraisal (RRNA) review methodology to systematically identify existing henipavirus evidence on clinical characteristics, immune response, transmission, risk factors, medical countermeasures and associated social and behavioural factors, to inform research prioritisation, and strategies to strengthen our preparedness and response for henipaviruses to protect populations and improve outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>We searched PubMed, Ovid Embase, Cochrane Library, Epistemonikos from 1974 to 15 May 2025 for studies focused on henipavirus infection including humans or human samples. Two reviewers screened studies and extracted data across predefined research domains without language restrictions. Data were analysed descriptively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 106 records included, most focused on Nipah (82.1%, 87\/106), followed by Hendra (17.9%, 19\/106) and Langya virus (1.9%, 2\/106) disease, set in Asia (82.1%, 87\/106), Australia (17.9%, 19\/106) and Europe (0.9%, 1\/106). Most (96.2%, 102\/106) were observational, 3.8% (4\/106) interventional studies. Adults were included in 76.4% (81\/106) studies, children in 32.1% (34\/106); pregnant women in 0.9% (1\/106). Studies focused on clinical characteristics (n=59), transmission (n=28), risk factors (n=16), social science (n=17), diagnostics (n=14), immune response (n=9), and therapeutics (n=4). Of the four interventional studies, two focused on medical countermeasures, including a non-randomised controlled Nipah ribavirin study and a phase I\u2009m102.4 antibody Nipah and Hendra treatment trial in adults. Two were social science studies: one a self-instruction prevention training module, the other a workshop on personal protective equipment. Human vaccine studies were lacking, but nine studies explored attitudes to vaccination of horses against Hendra virus.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our data highlight the limited evidence available and the lack of medical countermeasures for henipaviruses. The gaps in inclusion of high-risk populations (young children, pregnant women) are concerning. Our data show a need to identify effective medical countermeasures, supported by behavioural studies, and to invest in One Health studies to generate evidence to inform strategies to protect societies against the threat of henipaviruses.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjph-2025-004195","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T13:38:38Z","timestamp":1783345118000},"page":"e004195","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Henipavirus evidence gaps: a Rapid Research Needs Appraisal"],"prefix":"10.1136","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1464-0936","authenticated-orcid":false,"given":"Marieke","family":"de Swart","sequence":"first","affiliation":[{"name":"Policy and Practice Research Group, Pandemic Sciences Institute, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amen-Patrick","family":"Nwosu","sequence":"additional","affiliation":[{"name":"Policy and Practice Research Group, Pandemic Sciences Institute, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrena Ruth","family":"Frischer","sequence":"additional","affiliation":[{"name":"Policy and Practice Research Group, Pandemic Sciences Institute, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5474-7132","authenticated-orcid":false,"given":"Tara","family":"Hurst","sequence":"additional","affiliation":[{"name":"Pandemic Sciences Institute, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonela","family":"Ntamo","sequence":"additional","affiliation":[{"name":"Cochrane South Africa, Tygerberg, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dijana","family":"Spasenoska","sequence":"additional","affiliation":[{"name":"Policy and Practice Research Group, Pandemic Sciences Institute, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Zakiul","family":"Hassan","sequence":"additional","affiliation":[{"name":"Pandemic Sciences Institute, University of Oxford, Oxford, UK"},{"name":"Programme for Emerging Infections, Infectious Diseases Division, International Centre for Diarrhoeal Disease Research Bangladesh, Dhaka, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marakiya","family":"Moetlediwa","sequence":"additional","affiliation":[{"name":"Cochrane South Africa, Tygerberg, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisy Mdumei","family":"Mpando","sequence":"additional","affiliation":[{"name":"Policy and Practice Research Group, Pandemic Sciences Institute, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Buckley","sequence":"additional","affiliation":[{"name":"Cochrane Response, Cochrane, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1306-1721","authenticated-orcid":false,"given":"Gemma","family":"Villanueva","sequence":"additional","affiliation":[{"name":"Cochrane Response, Cochrane, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Henschke","sequence":"additional","affiliation":[{"name":"Cochrane Response, Cochrane, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Probyn","sequence":"additional","affiliation":[{"name":"Cochrane Response, Cochrane, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4635-8959","authenticated-orcid":false,"given":"Eli","family":"Harriss","sequence":"additional","affiliation":[{"name":"Bodleian Health Care Libraries, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Adhikari","sequence":"additional","affiliation":[{"name":"Policy and Practice Research Group, Pandemic Sciences Institute, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6162-4146","authenticated-orcid":false,"given":"Vincent","family":"Cheng","sequence":"additional","affiliation":[{"name":"NHS Foundation Trust, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duduzile","family":"Ndwandwe","sequence":"additional","affiliation":[{"name":"Cochrane South Africa, Tygerberg, South Africa"},{"name":"South African Medical Research Council, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8908-2775","authenticated-orcid":false,"given":"Alice","family":"Norton","sequence":"additional","affiliation":[{"name":"Policy and Practice Research Group, Pandemic Sciences Institute, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2764-1177","authenticated-orcid":false,"given":"Louise","family":"Sigfrid","sequence":"additional","affiliation":[{"name":"Policy and Practice Research Group, Pandemic Sciences Institute, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"2026070606151328000_4.3.e004195.1","unstructured":"World Health Organization . Prioritizing Diseases for Research and Development in Emergency Contexts. Geneva: World Health Organization, 2024. Available: https:\/\/www.who.int\/activities\/prioritizing-diseases-for-research-and-development-in-emergency-contexts [accessed 10 Jan 2024]."},{"key":"2026070606151328000_4.3.e004195.2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jcv.2019.05.009","article-title":"Case fatality rate and risk factors for Nipah virus encephalitis: a systematic review and meta-analysis","volume":"117","author":"Kenmoe","year":"2019","journal-title":"Journal of Clinical Virology"},{"key":"2026070606151328000_4.3.e004195.3","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.3201\/eid1812.120722","article-title":"No Evidence of Prolonged Hendra Virus Shedding by 2 Patients, Australia","volume":"18","author":"Taylor","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"2026070606151328000_4.3.e004195.4","doi-asserted-by":"crossref","unstructured":"Joshi J , Shah Y , Pandey K , et al . Possible high risk of transmission of the Nipah virus in South and South East Asia: a review. Trop Med Health 2023;51. doi:10.1186\/s41182-023-00535-7","DOI":"10.1186\/s41182-023-00535-7"},{"key":"2026070606151328000_4.3.e004195.5","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/infdis\/jiad467","article-title":"Potential for person-to-person transmission of henipaviruses: a systematic review of the literature","volume":"229","author":"Hegde","year":"2024","journal-title":"J Infect Dis"},{"key":"2026070606151328000_4.3.e004195.6","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3201\/eid2902.221379","article-title":"Nipah virus exposure in domestic and peridomestic animals living in human outbreak sites, Bangladesh, 2013\u20132015","volume":"29","author":"Islam","year":"2023","journal-title":"Emerg Infect Dis"},{"key":"2026070606151328000_4.3.e004195.7","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1002\/vms3.835","article-title":"Major bat-borne zoonotic viral epidemics in Asia and Africa: a systematic review and meta-analysis","volume":"8","author":"Khan","year":"2022","journal-title":"Vet Med Sci"},{"key":"2026070606151328000_4.3.e004195.8","doi-asserted-by":"publisher","DOI":"10.1126\/science.288.5470.1432"},{"key":"2026070606151328000_4.3.e004195.9","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1086\/338818","article-title":"Nipah virus encephalitis outbreak in Malaysia","volume":"34 Suppl 2","author":"Lam","year":"2002","journal-title":"Clin Infect Dis"},{"key":"2026070606151328000_4.3.e004195.10","doi-asserted-by":"publisher","DOI":"10.1080\/20477724.2024.2380131"},{"key":"2026070606151328000_4.3.e004195.11","unstructured":"World Health Organization . Nipah virus infection. 2023. Available: https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2023-DON442 [Accessed 11 Nov 2023]."},{"key":"2026070606151328000_4.3.e004195.12","doi-asserted-by":"crossref","unstructured":"de Campos GM , Cella E , Kashima S , et al . Updated insights into the phylogenetics, phylodynamics, and genetic diversity of nipah virus (NiV). Viruses 2024;16. doi:10.3390\/v16020171","DOI":"10.3390\/v16020171"},{"key":"2026070606151328000_4.3.e004195.13","doi-asserted-by":"crossref","unstructured":"Ang BSP , Lim TCC , Wang L . Nipah virus infection. J Clin Microbiol 2018;56. doi:10.1128\/JCM.01875-17","DOI":"10.1128\/JCM.01875-17"},{"key":"2026070606151328000_4.3.e004195.14","first-page":"103","article-title":"Nipah encephalitis - an update","volume":"69 Suppl A","author":"Sherrini","year":"2014","journal-title":"Med J Malaysia"},{"key":"2026070606151328000_4.3.e004195.15","doi-asserted-by":"crossref","unstructured":"Shariff M , Aditi . Nipah virus infection: a review. Epidemiol Infect 2019;147. doi:10.1017\/S0950268819000086","DOI":"10.1017\/S0950268819000086"},{"key":"2026070606151328000_4.3.e004195.16","unstructured":"World Health Organization . Nipah virus infection. 2023. Available: https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2023-DON490 [Accessed 3 Oct 2023]."},{"key":"2026070606151328000_4.3.e004195.17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200004273421701"},{"key":"2026070606151328000_4.3.e004195.18","doi-asserted-by":"publisher","DOI":"10.3988\/jcn.2023.0240"},{"key":"2026070606151328000_4.3.e004195.19","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1995.tb126050.x"},{"key":"2026070606151328000_4.3.e004195.20","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(12)70158-5"},{"key":"2026070606151328000_4.3.e004195.21","doi-asserted-by":"crossref","unstructured":"Mire CE , Satterfield BA , Geisbert TW . Pathogenesis of hendra virus in humans. Human Emerging and Re\u2010emerging Infections 2015;207\u201325. doi:10.1002\/9781118644843","DOI":"10.1002\/9781118644843.ch11"},{"key":"2026070606151328000_4.3.e004195.22","doi-asserted-by":"crossref","unstructured":"Taylor J , Thompson K , Annand EJ , et al . Novel variant Hendra virus genotype 2 infection in a horse in the greater Newcastle region, New South Wales, Australia. One Health 2022;15. doi:10.1016\/j.onehlt.2022.100423","DOI":"10.1016\/j.onehlt.2022.100423"},{"key":"2026070606151328000_4.3.e004195.23","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/d41586-022-02175-z","article-title":"New \u2018Langya\u2019 virus identified in China: what scientists know so far","volume":"608","author":"Mallapaty","year":"2022","journal-title":"Nature"},{"key":"2026070606151328000_4.3.e004195.24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2202705"},{"key":"2026070606151328000_4.3.e004195.25","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3201\/eid3103.241134","article-title":"Genetic diversity and geographic spread of henipaviruses","volume":"31","author":"Kane","year":"2025","journal-title":"Emerg Infect Dis"},{"key":"2026070606151328000_4.3.e004195.26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41541-021-00284-w","article-title":"A single dose investigational subunit vaccine for human use against Nipah virus and Hendra virus","volume":"6","author":"Geisbert","year":"2021","journal-title":"Npj Vaccines"},{"key":"2026070606151328000_4.3.e004195.27","unstructured":"Oxford Vaccine Group . First in-human vaccine trial for nipah virus. 2024. Available: https:\/\/www.ovg.ox.ac.uk\/news\/first-in-human-vaccine-trial-for-nipah-virus [Accessed 1 Nov 2024]."},{"key":"2026070606151328000_4.3.e004195.28","unstructured":"National Institute of Allergy and Infectious Diseases (NIAID) . Dose escalation, open-label clinical trial to evaluate safety, tolerability and immunogenicity of a nipah virus (NIV) mRNA vaccine, mRNA-1215. Available: https:\/\/clinicaltrials.gov\/study\/NCT05398796 [Accessed 25 Sep 2024]."},{"key":"2026070606151328000_4.3.e004195.29","unstructured":"National Institute of Allergy and Infectious Diseases (NIAID) . Safety and immunogenicity of a nipah virus vaccine (HeV-sG-V). Available: https:\/\/clinicaltrials.gov\/study\/NCT04199169 [Accessed 17 Nov 2022]."},{"key":"2026070606151328000_4.3.e004195.30","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1177\/17407745221105106","article-title":"Landscape of coronavirus disease 2019 clinical trials: New frontiers and challenges","volume":"19","author":"Halabi","year":"2022","journal-title":"Clin Trials"},{"key":"2026070606151328000_4.3.e004195.31","unstructured":"Global Research Collaboration for Infectious Disease Preparedness (GloPID-R) . GloPID-r funder living roadmap for clinical trial coordination. 2023. Available: https:\/\/www.glopid-r.org\/wp-content\/uploads\/2023\/04\/glopid-r-funders-living-roadmap-for-clinical-trial-coordination.pdf"},{"key":"2026070606151328000_4.3.e004195.32","doi-asserted-by":"crossref","first-page":"103294","DOI":"10.1016\/j.eclinm.2025.103294","article-title":"PEARLES challenges and solutions to the implementation of clinical research responses to epidemics and pandemics: a scoping review","volume":"85","author":"Crealock-Ashurst","year":"2025","journal-title":"eClinicalMedicine"},{"key":"2026070606151328000_4.3.e004195.33","doi-asserted-by":"crossref","unstructured":"Sigfrid L , Moore C , Salam AP , et al . A rapid research needs appraisal methodology to identify evidence gaps to inform clinical research priorities in response to outbreaks\u2014results from the Lassa fever pilot. BMC Med 2019;17. doi:10.1186\/s12916-019-1338-1","DOI":"10.1186\/s12916-019-1338-1"},{"key":"2026070606151328000_4.3.e004195.34","doi-asserted-by":"crossref","unstructured":"de Swart M , Spasenoska D , Harriss E , et al . Rapid Research Needs Appraisal (RRNA) for priority diseases living protocol [version 2; peer review: 1 approved, 1 approved with reservations]. Wellcome Open Res 2026;10. Available: https:\/\/doi.org\/10.12688\/wellcomeopenres.25003.2","DOI":"10.12688\/wellcomeopenres.25003.2"},{"key":"2026070606151328000_4.3.e004195.35","doi-asserted-by":"crossref","unstructured":"Page MJ , McKenzie JE , Bossuyt PM , et al . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372. doi:10.1136\/bmj.n71","DOI":"10.1136\/bmj.n71"},{"key":"2026070606151328000_4.3.e004195.36","unstructured":"DistillerSR Inc . DistillerSR. version 2.35. 2023."},{"key":"2026070606151328000_4.3.e004195.37","unstructured":"The End Note Team . EndNote. 21st edn. Philadelphia, PA: Clarivate, 2013."},{"key":"2026070606151328000_4.3.e004195.38","unstructured":"Team Rs . RStudio: Integrated Development for R. Boston, MA: RStudio, PBC, 2024."},{"key":"2026070606151328000_4.3.e004195.39","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30634-6"},{"key":"2026070606151328000_4.3.e004195.40","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2990.2008.00991.x"},{"key":"2026070606151328000_4.3.e004195.41","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.crad.2011.10.008","article-title":"MRI findings in acute Hendra virus meningoencephalitis","volume":"67","author":"Nakka","year":"2012","journal-title":"Clin Radiol"},{"key":"2026070606151328000_4.3.e004195.42","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4103\/jms.jms_79_22","article-title":"Cough in Langya henipavirus and severity of infection","volume":"37","author":"Joob","year":"2023","journal-title":"Journal of Medical Society"},{"key":"2026070606151328000_4.3.e004195.43","doi-asserted-by":"publisher","DOI":"10.1053\/jinf.2000.0782"},{"key":"2026070606151328000_4.3.e004195.44","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3201\/eid2401.161758","article-title":"Nipah virus contamination of hospital surfaces during outbreaks, Bangladesh, 2013\u20132014","volume":"24","author":"Hassan","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"2026070606151328000_4.3.e004195.45","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/cid\/ciy1092","article-title":"Persistence of nipah virus RNA in semen of survivor","volume":"69","author":"Arunkumar","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2026070606151328000_4.3.e004195.46","doi-asserted-by":"crossref","unstructured":"Watanabe S , Fukushi S , Harada T , et al . Effective inactivation of Nipah virus in serum samples for safe processing in low-containment laboratories. Virol J 2020;17. doi:10.1186\/s12985-020-01425-8","DOI":"10.1186\/s12985-020-01425-8"},{"key":"2026070606151328000_4.3.e004195.47","doi-asserted-by":"publisher","DOI":"10.1111\/vox.12888"},{"key":"2026070606151328000_4.3.e004195.48","doi-asserted-by":"publisher","DOI":"10.3201\/eid1012.040701"},{"key":"2026070606151328000_4.3.e004195.49","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1017\/S0950268815001314","article-title":"Evolving epidemiology of Nipah virus infection in Bangladesh: evidence from outbreaks during 2010-2011","volume":"144","author":"Chakraborty","year":"2016","journal-title":"Epidemiol Infect"},{"key":"2026070606151328000_4.3.e004195.50","doi-asserted-by":"publisher","DOI":"10.1007\/s10393-016-1166-0"},{"key":"2026070606151328000_4.3.e004195.51","doi-asserted-by":"publisher","DOI":"10.3201\/eid1902.120971"},{"key":"2026070606151328000_4.3.e004195.52","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1017\/S0317167100001785","article-title":"Nipah encephalitis outbreak in Malaysia, clinical features in patients from Seremban","volume":"29","author":"Chong","year":"2002","journal-title":"Can j neurol sci"},{"key":"2026070606151328000_4.3.e004195.53","doi-asserted-by":"publisher","DOI":"10.1086\/318822"},{"key":"2026070606151328000_4.3.e004195.54","doi-asserted-by":"publisher","DOI":"10.1086\/529147"},{"key":"2026070606151328000_4.3.e004195.55","doi-asserted-by":"crossref","first-page":"369","DOI":"10.4103\/apjtm.apjtm_957_23","article-title":"Advancing public health preparedness: establishment of Nipah virus molecular diagnostic test at the National Reference Laboratory, Sri Lanka","volume":"17","author":"Harshani","year":"2024","journal-title":"Asian Pac J Trop Med"},{"key":"2026070606151328000_4.3.e004195.56","doi-asserted-by":"crossref","unstructured":"Yadav PD , Sahay RR , Balakrishnan A , et al . Nipah virus outbreak in Kerala state, india amidst of COVID-19 pandemic. Front Public Health 2022;10. doi:10.3389\/fpubh.2022.818545","DOI":"10.3389\/fpubh.2022.818545"},{"key":"2026070606151328000_4.3.e004195.57","doi-asserted-by":"crossref","first-page":"645","DOI":"10.4103\/ijmr.IJMR_4717_20","article-title":"point-of-care test for rapid diagnosis of Nipah","volume":"154","author":"Yadav","year":"2021","journal-title":"Indian J Med Res"},{"key":"2026070606151328000_4.3.e004195.58","doi-asserted-by":"crossref","unstructured":"Bergeron \u00c9 , Chiang C-F , Lo MK , et al . Streamlined detection of Nipah virus antibodies using a split NanoLuc biosensor. Emerg Microbes Infect 2024;13. doi:10.1080\/22221751.2024.2398640","DOI":"10.1080\/22221751.2024.2398640"},{"key":"2026070606151328000_4.3.e004195.59","doi-asserted-by":"crossref","first-page":"429","DOI":"10.4103\/ijmr.ijmr_2737_21","article-title":"Development of Nipah virus-specific IgM & IgG ELISA for screening human serum samples","volume":"156","author":"Shete","year":"2022","journal-title":"Indian J Med Res"},{"key":"2026070606151328000_4.3.e004195.60","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4103\/ijmr.IJMR_4388_20","article-title":"Antibody response in symptomatic & asymptomatic Nipah virus cases from Kerala, India","volume":"154","author":"Shete","year":"2021","journal-title":"Indian J Med Res"},{"key":"2026070606151328000_4.3.e004195.61","doi-asserted-by":"crossref","first-page":"S370","DOI":"10.1093\/infdis\/jiaa085","article-title":"Seroprevalence of Nipah Virus Infection in Peninsular Malaysia","volume":"221","author":"Yong","year":"2020","journal-title":"J Infect Dis"},{"key":"2026070606151328000_4.3.e004195.62","doi-asserted-by":"crossref","unstructured":"Sahay RR , Palav HC , Shete AM , et al . Comparative immune profiling in survivors of the 2023 Nipah outbreak in Kerala state, India. J Med Virol 2024;96. doi:10.1002\/jmv.29920","DOI":"10.1002\/jmv.29920"},{"key":"2026070606151328000_4.3.e004195.63","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.71.4.552"},{"key":"2026070606151328000_4.3.e004195.64","doi-asserted-by":"crossref","first-page":"106398","DOI":"10.1016\/j.jinf.2024.106398","article-title":"Malaysia outbreak survivors retain detectable Nipah antibodies and memory B cells after 25 years","volume":"90","author":"Ong","year":"2025","journal-title":"J Infect"},{"key":"2026070606151328000_4.3.e004195.65","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/tropicalmed8010016","article-title":"Vertical transfer of humoral immunity against nipah virus: a novel evidence from Bangladesh","volume":"8","author":"Satter","year":"2023","journal-title":"TropicalMed"},{"key":"2026070606151328000_4.3.e004195.66","doi-asserted-by":"publisher","DOI":"10.1002\/ana.1062"},{"key":"2026070606151328000_4.3.e004195.67","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0140-6736(99)04379-2","article-title":"Outbreak of Nipah-virus infection among abattoir workers in Singapore","volume":"354","author":"Paton","year":"1999","journal-title":"The Lancet"},{"key":"2026070606151328000_4.3.e004195.68","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)04299-3"},{"key":"2026070606151328000_4.3.e004195.69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080897","article-title":"Hendra Virus and Horse Owners \u2013 Risk Perception and Management","volume":"8","author":"Kung","year":"2013","journal-title":"PLoS ONE"},{"key":"2026070606151328000_4.3.e004195.70","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.onehlt.2015.07.002","article-title":"Flying-foxes in the Australian urban environment-community attitudes and opinions","volume":"1","author":"Kung","year":"2015","journal-title":"One Health"},{"key":"2026070606151328000_4.3.e004195.71","doi-asserted-by":"crossref","unstructured":"Kropich-Grant JN , Wiley KE , Manyweathers J , et al . Communication interventions and assessment of drivers for hendra virus vaccination uptake. Vaccines (Basel) 2023;11. doi:10.3390\/vaccines11050936","DOI":"10.3390\/vaccines11050936"},{"key":"2026070606151328000_4.3.e004195.72","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/avj.12957","article-title":"Citizens\u2019 juries give verdict on whether private practice veterinarians should attend unvaccinated Hendra virus suspect horses","volume":"98","author":"Annand","year":"2020","journal-title":"Aust Vet J"},{"key":"2026070606151328000_4.3.e004195.73","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/avj.13099","article-title":"The Hendra virus vaccine: perceptions regarding the role of antibody titre testing","volume":"99","author":"Barrett","year":"2021","journal-title":"Aust Vet J"},{"key":"2026070606151328000_4.3.e004195.74","doi-asserted-by":"crossref","unstructured":"Mendez DH , B\u00fcttner P , Kelly J , et al . Difficulties experienced by veterinarians when communicating about emerging zoonotic risks with animal owners: the case of Hendra virus. BMC Vet Res 2017;13. doi:10.1186\/s12917-017-0970-2","DOI":"10.1186\/s12917-017-0970-2"},{"key":"2026070606151328000_4.3.e004195.75","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.prevetmed.2017.03.003","article-title":"\u201cWe\u2019ve learned to live with it\u201d\u2014A qualitative study of Australian horse owners\u2019 attitudes, perceptions and practices in response to Hendra virus","volume":"140","author":"Wiethoelter","year":"2017","journal-title":"Prev Vet Med"},{"key":"2026070606151328000_4.3.e004195.76","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.prevetmed.2014.08.002","article-title":"Hendra virus in Queensland, Australia, during the winter of 2011: Veterinarians on the path to better management strategies","volume":"117","author":"Mendez","year":"2014","journal-title":"Prev Vet Med"},{"key":"2026070606151328000_4.3.e004195.77","doi-asserted-by":"crossref","first-page":"1017452","DOI":"10.3389\/fvets.2022.1017452","article-title":"Willingness to adopt personal biosecurity strategies on thoroughbred breeding farms: Findings from a multi-site pilot study in Australia\u2019s Hunter Valley","volume":"9","author":"Thompson","year":"2022","journal-title":"Front Vet Sci"},{"key":"2026070606151328000_4.3.e004195.78","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1111\/tbed.12588","article-title":"Risk mitigation of emerging zoonoses: hendra virus and non-vaccinating horse owners","volume":"64","author":"Manyweathers","year":"2017","journal-title":"Transbound Emerg Dis"},{"key":"2026070606151328000_4.3.e004195.79","doi-asserted-by":"crossref","first-page":"100389","DOI":"10.1016\/j.jve.2024.100389","article-title":"Knowledge and attitude among Bangladeshi healthcare workers regarding the management and infection prevention and control of Nipah virus","volume":"10","author":"Islam","year":"2024","journal-title":"J Virus Erad"},{"key":"2026070606151328000_4.3.e004195.80","doi-asserted-by":"crossref","first-page":"849","DOI":"10.37506\/ijfmt.v15i2.14419","article-title":"Assess the effectiveness of self-instruction module on knowledge regarding nipah virus infection and its prevention among general population","volume":"15","author":"Sheetal","year":"2021","journal-title":"Indian Journal of Forensic Medicine & Toxicology"},{"key":"2026070606151328000_4.3.e004195.81","doi-asserted-by":"crossref","unstructured":"Mohamed F , Uvais NA , Shihabudheen P , et al . Assessing psychological morbidities in hospital staff during nipah virus concerns. Prim Care Companion CNS Disord 2025;27. doi:10.4088\/PCC.24m03818","DOI":"10.4088\/PCC.24m03818"},{"key":"2026070606151328000_4.3.e004195.82","doi-asserted-by":"crossref","first-page":"e463","DOI":"10.1016\/S1473-3099(23)00707-7","article-title":"Nipah virus disease: what can we do to improve patient care?","volume":"24","author":"Hassan","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"2026070606151328000_4.3.e004195.83","doi-asserted-by":"crossref","first-page":"101002","DOI":"10.1016\/j.lanmic.2024.101002","article-title":"Therapeutics for Nipah virus disease: a systematic review to support prioritisation of drug candidates for clinical trials","volume":"6","author":"Chan","year":"2025","journal-title":"The Lancet Microbe"},{"key":"2026070606151328000_4.3.e004195.84","unstructured":"Pandemic PACT Research Programme . Grant and Evidence Gap Tracker by the Pandemic PACT Team with GloPID-R and UKCDR. Available: www.pandemicpact.org [Accessed 16 Apr 2026]."},{"key":"2026070606151328000_4.3.e004195.85","unstructured":"World Health Organization . Nipah Virus Research and Development (R&D) Roadmap. Geneva: World Health Organization, 2019. Available: https:\/\/www.who.int\/publications\/m\/item\/nipah-research-and-development-(r-d)-roadmap"},{"key":"2026070606151328000_4.3.e004195.86","unstructured":"Oxford vaccine against deadly Nipah virus granted European Medicines Agency PRIME designation 2025, Available: https:\/\/www.ox.ac.uk\/news\/2025-06-09-oxford-vaccine-against-deadly-nipah-virus-granted-european-medicines-agency-prime [Accessed 10 Jun 2025]."},{"key":"2026070606151328000_4.3.e004195.87","doi-asserted-by":"crossref","first-page":"100527","DOI":"10.1016\/j.lansea.2024.100527","article-title":"Improving clinical care of patients in Nipah outbreaks: moving beyond \u2018compassionate use\u2019","volume":"33","author":"Hassan","year":"2025","journal-title":"The Lancet Regional Health - Southeast Asia"},{"key":"2026070606151328000_4.3.e004195.88","unstructured":"Viergever RF , Olifson S , Ghaffar A , et al . Setting Research Priorities in Global Health: A Practical Guide. Geneva: COHRED, 2010."},{"key":"2026070606151328000_4.3.e004195.89","doi-asserted-by":"publisher","DOI":"10.1136\/jme-2023-109469"},{"key":"2026070606151328000_4.3.e004195.90","doi-asserted-by":"crossref","unstructured":"McLean RK , Graham SP . Vaccine development for nipah virus infection in pigs. Front Vet Sci 2019;6. doi:10.3389\/fvets.2019.00016","DOI":"10.3389\/fvets.2019.00016"},{"key":"2026070606151328000_4.3.e004195.91","doi-asserted-by":"crossref","unstructured":"Radhakrishnan C , Sankar UV , Rajendran VR , et al . Psychosocial impacts of quarantine among survivors of the Nipah virus infection: a qualitative study. J Glob Health Rep 2021;5. doi:10.29392\/001c.28993","DOI":"10.29392\/001c.28993"},{"key":"2026070606151328000_4.3.e004195.92","unstructured":"Paramyxoviridae Research and Development Roadmap. Geneva: World Health Organization, 2026. Available: https:\/\/cdn.who.int\/media\/docs\/default-source\/consultation-rdb\/paramyxovirus-r-d-roadmap.pdf"},{"key":"2026070606151328000_4.3.e004195.93","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.3201\/eid1110.050513","article-title":"Genetic characterization of nipah virus, Bangladesh, 2004","volume":"11","author":"Harcourt","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"2026070606151328000_4.3.e004195.94","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3201\/eid2102.141433","article-title":"Outbreak of henipavirus infection","volume":"21","author":"Ching","year":"2014","journal-title":"Emerging Infect Dis"},{"key":"2026070606151328000_4.3.e004195.95","unstructured":"South-East Asia Regional Roadmap for Diagnostic Preparedness, Integrated Laboratory Networking and Genomic Surveillance (2023\u20132027). New Delhi: World Health Organization Regional Office for South-East Asia, 2022. Available: https:\/\/www.who.int\/publications\/i\/item\/9789290209942"},{"key":"2026070606151328000_4.3.e004195.96","unstructured":"Pathogens Prioritization: A Scientific Framework for Epidemic and Pandemic Research Preparedness. Geneva: World Health Organization, 2024. Available: https:\/\/www.who.int\/publications\/m\/item\/pathogens-prioritization-a-scientific-framework-for-epidemic-and-pandemic-research-preparedness"},{"key":"2026070606151328000_4.3.e004195.97","doi-asserted-by":"crossref","unstructured":"Thien DH , Tran HB , Uyen NNP , et al . A comprehensive review of Langya virus and framework for future zoonotic disease control. Rev Med Virol 2024;34. doi:10.1002\/rmv.2520","DOI":"10.1002\/rmv.2520"},{"key":"2026070606151328000_4.3.e004195.98","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12939-025-02752-4","article-title":"Heterogeneity in vaccination attitudes and behavior within an outwardly homogenous religious group: a cross-sectional study of the Ultra-Orthodox Jewish population in Safed, Israel","volume":"25","author":"Jacobson","year":"2025","journal-title":"Int J Equity Health"},{"key":"2026070606151328000_4.3.e004195.99","doi-asserted-by":"crossref","unstructured":"Rojek AM , Horby PW . Modernising epidemic science: enabling patient-centred research during epidemics. BMC Med 2016;14. doi:10.1186\/s12916-016-0760-x","DOI":"10.1186\/s12916-016-0760-x"}],"container-title":["BMJ Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjph-2025-004195","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T13:39:59Z","timestamp":1783345199000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjpublichealth.bmj.com\/lookup\/doi\/10.1136\/bmjph-2025-004195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":99,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,7,6]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1136\/bmjph-2025-004195"],"URL":"https:\/\/doi.org\/10.1136\/bmjph-2025-004195","relation":{},"ISSN":["2753-4294"],"issn-type":[{"value":"2753-4294","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}